Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07211061Phase 4Completed
Phase 4, randomised trial of stannous fluoride and cetylpyridinium chloride in gingivitis (2 arms), sponsored by Procter & Gamble. Primary endpoint: Gingival Bleeding Index at 6 weeks. Started Sep 2011; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07211061.